DK169478B1 - 7-oxomitosan-derivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse - Google Patents

7-oxomitosan-derivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse Download PDF

Info

Publication number
DK169478B1
DK169478B1 DK401385A DK401385A DK169478B1 DK 169478 B1 DK169478 B1 DK 169478B1 DK 401385 A DK401385 A DK 401385A DK 401385 A DK401385 A DK 401385A DK 169478 B1 DK169478 B1 DK 169478B1
Authority
DK
Denmark
Prior art keywords
formula
derivative according
pharmaceutically acceptable
reaction
derivative
Prior art date
Application number
DK401385A
Other languages
Danish (da)
English (en)
Other versions
DK401385A (da
DK401385D0 (da
Inventor
Dolatrai Mohanlal Vyas
Terrence William Doyle
Richard A Partyka
Original Assignee
Squibb Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb Bristol Myers Co filed Critical Squibb Bristol Myers Co
Publication of DK401385D0 publication Critical patent/DK401385D0/da
Publication of DK401385A publication Critical patent/DK401385A/da
Application granted granted Critical
Publication of DK169478B1 publication Critical patent/DK169478B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK401385A 1984-09-04 1985-09-03 7-oxomitosan-derivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse DK169478B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US64688884A 1984-09-04 1984-09-04
US64688884 1984-09-04
US74457085A 1985-06-17 1985-06-17
US74457085 1985-06-17

Publications (3)

Publication Number Publication Date
DK401385D0 DK401385D0 (da) 1985-09-03
DK401385A DK401385A (da) 1986-03-05
DK169478B1 true DK169478B1 (da) 1994-11-07

Family

ID=27095036

Family Applications (1)

Application Number Title Priority Date Filing Date
DK401385A DK169478B1 (da) 1984-09-04 1985-09-03 7-oxomitosan-derivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse

Country Status (24)

Country Link
JP (1) JPS61112078A (ko)
KR (2) KR900008570B1 (ko)
AT (1) AT394723B (ko)
AU (1) AU581673B2 (ko)
BE (1) BE903169A (ko)
CA (2) CA1291293C (ko)
CH (2) CH667457A5 (ko)
CY (2) CY1585A (ko)
DE (1) DE3531453C2 (ko)
DK (1) DK169478B1 (ko)
ES (3) ES8702408A1 (ko)
FI (1) FI80700C (ko)
FR (1) FR2569696B1 (ko)
GB (2) GB2164038B (ko)
GR (1) GR852118B (ko)
HK (2) HK22391A (ko)
HU (1) HU195658B (ko)
IE (1) IE58720B1 (ko)
IT (1) IT1209660B (ko)
LU (1) LU86062A1 (ko)
NL (1) NL8502383A (ko)
NO (1) NO169441C (ko)
PT (1) PT81083B (ko)
SE (2) SE465929B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803212A (en) * 1983-04-11 1989-02-07 Bristol-Myers Company Amino disulfides
US4888341A (en) * 1984-09-04 1989-12-19 University Patents, Inc. 6-substituted mitomycin analogs
IL86665A0 (en) * 1987-06-12 1988-11-30 Bristol Myers Co Mitomycin analogs
ZA886812B (en) * 1987-11-23 1989-07-26 Bristol Myers Co Anti-tumor prodrugs
US5023253A (en) * 1987-12-21 1991-06-11 University Patents, Inc. 6-substituted mitomycin analogs
US5175303A (en) * 1990-03-08 1992-12-29 Bristol-Myers Squibb Company Preparation of 7-(diphenylmethyl)oxy-9A-methoxymitosane
US5075454A (en) * 1990-03-08 1991-12-24 Bristol-Myers Squibb Company 7-(diphenylmethyl)oxy-9a-methoxymitosane

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3306821A (en) * 1962-09-04 1967-02-28 Upjohn Co Porfiromycin derivatives and method of making same
US4487769A (en) * 1982-06-04 1984-12-11 Bristol-Myers Company Amidines
DE3376114D1 (en) * 1982-12-07 1988-05-05 Kyowa Hakko Kogyo Kk Mitomycin analogues
JPS59175493A (ja) * 1983-03-25 1984-10-04 Kyowa Hakko Kogyo Co Ltd マイトマイシン誘導体
KR840008362A (ko) * 1983-04-11 1984-12-14 사무엘 제이. 두보프 아미노 이황산염
US4803212A (en) * 1983-04-11 1989-02-07 Bristol-Myers Company Amino disulfides
US4888341A (en) * 1984-09-04 1989-12-19 University Patents, Inc. 6-substituted mitomycin analogs

Also Published As

Publication number Publication date
ES553548A0 (es) 1987-06-16
HK22491A (en) 1991-04-04
GB2164038A (en) 1986-03-12
KR900008840B1 (ko) 1990-11-30
CY1585A (en) 1992-04-03
IE852174L (en) 1986-03-04
DK401385A (da) 1986-03-05
GB8726516D0 (en) 1987-12-16
FI80700B (fi) 1990-03-30
AU581673B2 (en) 1989-03-02
CY1586A (en) 1992-04-03
GB2196006B (en) 1988-11-09
JPS61112078A (ja) 1986-05-30
SE465929B (sv) 1991-11-18
JPH0560469B2 (ko) 1993-09-02
ES546687A0 (es) 1986-12-16
FI853338A0 (fi) 1985-08-30
AU4571685A (en) 1986-03-13
GB8521816D0 (en) 1985-10-09
SE9004157L (sv) 1992-06-28
PT81083A (en) 1985-10-01
ES8702408A1 (es) 1986-12-16
FI853338L (fi) 1986-03-05
HUT38942A (en) 1986-07-28
NL8502383A (nl) 1986-04-01
NO169441C (no) 1992-06-24
DE3531453A1 (de) 1986-03-13
FR2569696B1 (fr) 1991-12-20
CH667094A5 (de) 1988-09-15
GB2196006A (en) 1988-04-20
AT394723B (de) 1992-06-10
CA1254892A (en) 1989-05-30
ES8706326A1 (es) 1987-06-16
IT8522059A0 (it) 1985-09-03
NO169441B (no) 1992-03-16
KR860002507A (ko) 1986-04-26
SE9004157D0 (sv) 1990-12-27
FI80700C (fi) 1990-07-10
SE8504093D0 (sv) 1985-09-03
DK401385D0 (da) 1985-09-03
CA1291293C (en) 1991-10-22
PT81083B (pt) 1988-01-22
NO853435L (no) 1986-03-05
IT1209660B (it) 1989-08-30
HK22391A (en) 1991-04-04
HU195658B (en) 1988-06-28
DE3531453C2 (de) 1996-07-18
GB2164038B (en) 1988-11-09
GR852118B (ko) 1986-01-07
FR2569696A1 (fr) 1986-03-07
ES553549A0 (es) 1987-06-16
IE58720B1 (en) 1993-11-03
KR900008570B1 (ko) 1990-11-24
ATA258985A (de) 1991-11-15
CH667457A5 (de) 1988-10-14
SE8504093L (sv) 1986-03-05
ES8706327A1 (es) 1987-06-16
BE903169A (fr) 1986-03-03
LU86062A1 (fr) 1986-03-03

Similar Documents

Publication Publication Date Title
JP6267397B1 (ja) 置換された多環性ピリドン誘導体およびそのプロドラッグを含有する医薬組成物
KR102677015B1 (ko) Bet 억제제로서의 헤테로시클릭 화합물
KR20190140910A (ko) 아폽토시스-유도제
WO2020092638A1 (en) Heterocyclic compounds as bet inhibitors
DK169478B1 (da) 7-oxomitosan-derivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse
KR940006629B1 (ko) 아미노 디설파이드 티올 교환생성물의 제조방법
WO2023036974A1 (en) Spirocyclic compounds
DK162167B (da) Analogifremgangsmaade til fremstilling af mitosanderivater
CZ286180B6 (cs) 6,9-bis(Substituované amino)benzo/g/isochinolin-5 10-diony
Zhang et al. Antitumor Agents. 148. Synthesis and Biological Evaluation of Novel 4. beta.-Amino Derivatives of Etoposide with Better Pharmacological Profiles
AU2020410900B2 (en) Compound used as RET kinase inhibitor and application thereof
KR890001488B1 (ko) 미토마이신 c 유도체의 제조방법
JP6858252B2 (ja) ラパマイシンシグナル伝達経路阻害剤のメカニズム標的、及びその治療応用
EP0556585A2 (en) Condensed camptothecin derivatives their production and use as antitumor agents
US4814445A (en) Process for preparing mitomycin analogs
CN113801113A (zh) 芳基或杂芳基并吡啶酮或嘧啶酮类衍生物及其制备方法和应用
EP0329126B1 (en) Heterocyclic compounds and antiulcer agents
US4927943A (en) Substituted 7-oxomitosanes
CZ34625U1 (cs) Inhibitory purinnukleosidfosforylasy k léčení T-buněčné akutní lymfoblastické leukémie a lymfomů
JPS59205382A (ja) アミノ２硫化物
FI79111C (fi) Foerfarande foer framstaellning av terapeutiskt vaerdefulla 1,3-dihydro-6-aminometyl-7-hydroxi-furo- (3,4-c)-pyridinderivat.
Visnevska et al. Evaluation of (E)-2-chlorovinylsulfones as novel class of cytotoxic agents and highly (E)-stereoselective addition of N-, S-and Senucleophiles to (E)-2-chlorovinylsulfones under phase transfer catalysis conditions